INDUSTRY OVERVIEW
The IVF market is experiencing robust growth, projected to achieve a compound annual growth rate CAGR of 10% during the forecast period. Valued at 15Billion, the market is expected to reach 25Billion by 2030, with a year-on-year growth rate of 9%. This upward trajectory is driven by factors such as evolving consumer preferences, technological advancements, and increased investment in innovation, positioning the market for significant expansion in the coming years. Companies should strategically focus on enhancing their offerings and exploring new market opportunities to capitalize on this growth potential.
IVF Market Size in (USD Billion) CAGR Growth Rate 10%
| Study Period |
2019-2030 |
| Market Size (2023): |
15Billion |
| Market Size (2030): |
25Billion |
| CAGR (2023 - 2030): |
10% |
| Fastest Growing Region |
Asia Pacific |
| Dominating Region |
North America |
www.www.htfmarketinsights.com
The IVF market focuses on assisted reproductive technologies, primarily in vitro fertilization (IVF), which helps couples with fertility issues conceive. The market includes egg freezing, sperm donation, and genetic testing.
Regulatory Framework
The Information and Communications Technology (ICT) industry is primarily regulated by the Federal Communications Commission (FCC) in the United States, along with other national and international regulatory bodies. The FCC oversees the allocation of spectrum, ensures compliance with telecommunications laws, and fosters fair competition within the sector. It also establishes guidelines for data privacy, cybersecurity, and service accessibility, which are crucial for maintaining industry standards and protecting consumer interests.
Globally, various regulatory agencies, such as the European Telecommunications Standards Institute (ETSI) and the International Telecommunication Union (ITU), play significant roles in standardizing practices and facilitating international cooperation. These bodies work together to create a cohesive regulatory framework that addresses emerging technologies, cross-border data flow, and infrastructure development. Their regulations aim to ensure the ICT industry's growth is both innovative and compliant with global standards, promoting a secure and competitive market environment.
Request for Customization
Get Customization
Key Highlights
• The IVF is growing at a CAGR of 10% during the forecasted period of 2019 to 2030
• Year on Year growth for the market is 9%
• Based on type, the market is bifurcated into In Vitro Fertilization, Egg Freezing, Sperm Donation, Cryopreservation
• Based on application, the market is segmented into Hospitals, Clinics, Research Institutes, Fertility Centers
• Global Import Export in terms of K Tons, K Units, and Metric Tons will be provided if Applicable based on industry best practice
Market Segmentation Analysis
Segmentation by Type
- In Vitro Fertilization
- Egg Freezing
- Sperm Donation
- Cryopreservation
IVF Market Segmentation by Type
www.htfmarketinsights.com
Segmentation by Application
- Hospitals
- Clinics
- Research Institutes
- Fertility Centers
IVF Market Segmentation by Application
www.htfmarketinsights.com
Key Players
Several key players in the IVF market are strategically focusing on expanding their operations in developing regions to capture a larger market share, particularly as the year-on-year growth rate for the market stands at 9%. The companies featured in this profile were selected based on insights from primary experts, evaluating their market penetration, product offerings, and geographical reach. By targeting emerging markets, these companies aim to leverage new opportunities, enhance their competitive advantage, and drive revenue growth. This approach not only aligns with their overall business objectives but also positions them to respond effectively to the evolving demands of consumers in these regions.
- Merck KGaA
- Cook Medical
- Vitrolife
- Irvine Scientific
- Ferring Pharmaceuticals
- EMD Serono
- The Cooper Companies
- IBSA
- OvaScience
- Reproductive Medicine Associates
- Bayer
- Igenomix
- RMA Network
- Genea
IVF Market Segmentation by Players
www.htfmarketinsights.com
Research Methodology
At HTF Market Intelligence, we pride ourselves on delivering comprehensive market research that combines both secondary and primary methodologies. Our secondary research involves rigorous analysis of existing data sources, such as industry reports, market databases, and competitive landscapes, to provide a robust foundation of market knowledge. This is complemented by our primary research services, where we gather firsthand data through surveys, interviews, and focus groups tailored specifically to your business needs. By integrating these approaches, we offer a thorough understanding of market trends, consumer behavior, and competitive dynamics, enabling you to make well-informed strategic decisions. We would welcome the opportunity to discuss how our research expertise can support your business objectives.
Market Dynamics
Market dynamics refer to the forces that influence the supply and demand of products and services within a market. These forces include factors such as consumer preferences, technological advancements, regulatory changes, economic conditions, and competitive actions. Understanding market dynamics is crucial for businesses as it helps them anticipate changes, identify opportunities, and mitigate risks.
By analyzing market dynamics, companies can better understand market trends, predict potential shifts, and develop strategic responses. This analysis enables businesses to align their product offerings, pricing strategies, and marketing efforts with evolving market conditions, ultimately leading to more informed decision-making and a stronger competitive position in the marketplace.
Market Driver
- Growth In Fertility Preservation
- Expansion Of IVF Services
Market Trend
- Advancements in genetic screening
- rise of personalized IVF treatments
Opportunity
- Growth In Fertility Preservation
- Expansion Of IVF Services
Challenge
- High Treatment Costs
- Ethical Concerns
Regional Outlook
The North America Region holds the largest market share in 2023 and is expected to grow at a good CAGR. The Asia Pacific Region is the fastest-growing region due to increasing development and disposable income.
North America remains a leader, driven by innovation hubs like Silicon Valley and a strong demand for advanced technologies such as AI and cloud computing. Europe is characterized by robust regulatory frameworks and significant investments in digital transformation across sectors. Asia-Pacific is experiencing rapid growth, led by major markets like China and India, where increasing digital adoption and governmental initiatives are propelling ICT advancements.
The Middle East and Africa are witnessing steady expansion, driven by infrastructure development and growing internet penetration. Latin America and South America present emerging opportunities, with rising investments in digital infrastructure, though challenges like economic instability can impact growth. These regional differences highlight the need for tailored strategies in the global ICT market.
Regions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
Asia Pacific
Dominating Region
North America
|
Report Features
|
Details
|
|
Base Year
|
2023
|
|
Based Year Market Size (2023)
|
15Billion
|
|
Historical Period Market Size (2019)
|
12Billion
|
|
CAGR (2023 to 2030)
|
10%
|
|
Forecast Period
|
2025 to 2030
|
|
Forecasted Period Market Size (2030)
|
25Billion
|
|
Scope of the Report
|
In Vitro Fertilization, Egg Freezing, Sperm Donation, Cryopreservation, Hospitals, Clinics, Research Institutes, Fertility Centers
|
|
Regions Covered
|
North America, Europe, Asia Pacific, South America, and MEA
|
|
Year on Year Growth
|
9%
|
|
Companies Covered
|
Merck KGaA, Cook Medical, Vitrolife, Irvine Scientific, Ferring Pharmaceuticals, EMD Serono, The Cooper Companies, IBSA, OvaScience, Reproductive Medicine Associates, Bayer, Igenomix, RMA Network, Genea
|
|
Customization Scope
|
15% Free Customization (For EG)
|
|
Delivery Format
|
PDF and Excel through Email
|
IVF - Table of Contents
Chapter 1: Market Preface
- 1.1 Global IVF Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global IVF Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global IVF Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 Growth in fertility preservation
- 3.1.2 expansion of IVF services
-
3.2 Available Opportunities
- 3.2.1 Growth in fertility preservation
-
3.3 Influencing Trends
- 3.3.1 Advancements in genetic screenin
-
3.4 Challenges
- 3.4.1 High treatment costs
- 3.4.2 ethical co
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global IVF Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of IVF Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
- 4.9 Impact of Tariff War
Chapter 5: IVF : Competition Benchmarking & Performance Evaluation
- 5.1 Global IVF Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by IVF Revenue 2023
- 5.3 BCG Matrix
- 5.3 Market Entropy
- 5.4 FPNV Positioning Matrix
- 5.5 Heat Map Analysis
Chapter 6: Global IVF Market: Company Profiles
- 6.1 Merck KGaA
- 6.1.1 Merck KGaA Company Overview
- 6.1.2 Merck KGaA Product/Service Portfolio & Specifications
- 6.1.3 Merck KGaA Key Financial Metrics
- 6.1.4 Merck KGaA SWOT Analysis
- 6.1.5 Merck KGaA Development Activities
- 6.2 Cook Medical
- 6.3 Vitrolife
- 6.4 Irvine Scientific
- 6.5 Ferring Pharmaceuticals
- 6.6 EMD Serono
- 6.7 The Cooper Companies
- 6.8 IBSA
- 6.9 OvaScience
- 6.10 Reproductive Medicine Associates
- 6.11 Bayer
- 6.12 Igenomix
- 6.13 RMA Network
- 6.14 Genea
- 6.15 Meda
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global IVF by Type & Application (2019-2030)
-
7.1 Global IVF Market Revenue Analysis (USD Million) by Type (2019-2023)
- 7.1.1 In Vitro Fertilization
- 7.1.2 Egg Freezing
- 7.1.3 Sperm Donation
- 7.1.4 Cryopreservation
- 7.1.5 Genetic Screening
-
7.2 Global IVF Market Revenue Analysis (USD Million) by Application (2019-2023)
- 7.2.1 Hospitals
- 7.2.2 Clinics
- 7.2.3 Research Institutes
- 7.2.4 Fertility Centers
-
7.3 Global IVF Market Revenue Analysis (USD Million) by Type (2023-2030)
-
7.4 Global IVF Market Revenue Analysis (USD Million) by Application (2023-2030)
Chapter 8 : North America IVF Market Breakdown by Country, Type & Application
- 8.1 North America IVF Market by Country (USD Million) [2019-2023]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America IVF Market by Type (USD Million) [2019-2023]
- 8.2.1 In Vitro Fertilization
- 8.2.2 Egg Freezing
- 8.2.3 Sperm Donation
- 8.2.4 Cryopreservation
- 8.2.5 Genetic Screening
-
8.3 North America IVF Market by Application (USD Million) [2019-2023]
- 8.3.1 Hospitals
- 8.3.2 Clinics
- 8.3.3 Research Institutes
- 8.3.4 Fertility Centers
- 8.4 North America IVF Market by Country (USD Million) [2024-2030]
-
8.5 North America IVF Market by Type (USD Million) [2024-2030]
-
8.6 North America IVF Market by Application (USD Million) [2024-2030]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM IVF Market Breakdown by Country, Type & Application
- 9.1 LATAM IVF Market by Country (USD Million) [2019-2023]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM IVF Market by Type (USD Million) [2019-2023]
- 9.2.1 In Vitro Fertilization
- 9.2.2 Egg Freezing
- 9.2.3 Sperm Donation
- 9.2.4 Cryopreservation
- 9.2.5 Genetic Screening
-
9.3 LATAM IVF Market by Application (USD Million) [2019-2023]
- 9.3.1 Hospitals
- 9.3.2 Clinics
- 9.3.3 Research Institutes
- 9.3.4 Fertility Centers
- 9.4 LATAM IVF Market by Country (USD Million) [2024-2030]
-
9.5 LATAM IVF Market by Type (USD Million) [2024-2030]
-
9.6 LATAM IVF Market by Application (USD Million) [2024-2030]
Chapter 10 : West Europe IVF Market Breakdown by Country, Type & Application
- 10.1 West Europe IVF Market by Country (USD Million) [2019-2023]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe IVF Market by Type (USD Million) [2019-2023]
- 10.2.1 In Vitro Fertilization
- 10.2.2 Egg Freezing
- 10.2.3 Sperm Donation
- 10.2.4 Cryopreservation
- 10.2.5 Genetic Screening
-
10.3 West Europe IVF Market by Application (USD Million) [2019-2023]
- 10.3.1 Hospitals
- 10.3.2 Clinics
- 10.3.3 Research Institutes
- 10.3.4 Fertility Centers
- 10.4 West Europe IVF Market by Country (USD Million) [2024-2030]
-
10.5 West Europe IVF Market by Type (USD Million) [2024-2030]
-
10.6 West Europe IVF Market by Application (USD Million) [2024-2030]
Chapter 11 : Central & Eastern Europe IVF Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe IVF Market by Country (USD Million) [2019-2023]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe IVF Market by Type (USD Million) [2019-2023]
- 11.2.1 In Vitro Fertilization
- 11.2.2 Egg Freezing
- 11.2.3 Sperm Donation
- 11.2.4 Cryopreservation
- 11.2.5 Genetic Screening
-
11.3 Central & Eastern Europe IVF Market by Application (USD Million) [2019-2023]
- 11.3.1 Hospitals
- 11.3.2 Clinics
- 11.3.3 Research Institutes
- 11.3.4 Fertility Centers
- 11.4 Central & Eastern Europe IVF Market by Country (USD Million) [2024-2030]
-
11.5 Central & Eastern Europe IVF Market by Type (USD Million) [2024-2030]
-
11.6 Central & Eastern Europe IVF Market by Application (USD Million) [2024-2030]
Chapter 12 : Northern Europe IVF Market Breakdown by Country, Type & Application
- 12.1 Northern Europe IVF Market by Country (USD Million) [2019-2023]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe IVF Market by Type (USD Million) [2019-2023]
- 12.2.1 In Vitro Fertilization
- 12.2.2 Egg Freezing
- 12.2.3 Sperm Donation
- 12.2.4 Cryopreservation
- 12.2.5 Genetic Screening
-
12.3 Northern Europe IVF Market by Application (USD Million) [2019-2023]
- 12.3.1 Hospitals
- 12.3.2 Clinics
- 12.3.3 Research Institutes
- 12.3.4 Fertility Centers
- 12.4 Northern Europe IVF Market by Country (USD Million) [2024-2030]
-
12.5 Northern Europe IVF Market by Type (USD Million) [2024-2030]
-
12.6 Northern Europe IVF Market by Application (USD Million) [2024-2030]
Chapter 13 : Southern Europe IVF Market Breakdown by Country, Type & Application
- 13.1 Southern Europe IVF Market by Country (USD Million) [2019-2023]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe IVF Market by Type (USD Million) [2019-2023]
- 13.2.1 In Vitro Fertilization
- 13.2.2 Egg Freezing
- 13.2.3 Sperm Donation
- 13.2.4 Cryopreservation
- 13.2.5 Genetic Screening
-
13.3 Southern Europe IVF Market by Application (USD Million) [2019-2023]
- 13.3.1 Hospitals
- 13.3.2 Clinics
- 13.3.3 Research Institutes
- 13.3.4 Fertility Centers
- 13.4 Southern Europe IVF Market by Country (USD Million) [2024-2030]
-
13.5 Southern Europe IVF Market by Type (USD Million) [2024-2030]
-
13.6 Southern Europe IVF Market by Application (USD Million) [2024-2030]
Chapter 14 : East Asia IVF Market Breakdown by Country, Type & Application
- 14.1 East Asia IVF Market by Country (USD Million) [2019-2023]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia IVF Market by Type (USD Million) [2019-2023]
- 14.2.1 In Vitro Fertilization
- 14.2.2 Egg Freezing
- 14.2.3 Sperm Donation
- 14.2.4 Cryopreservation
- 14.2.5 Genetic Screening
-
14.3 East Asia IVF Market by Application (USD Million) [2019-2023]
- 14.3.1 Hospitals
- 14.3.2 Clinics
- 14.3.3 Research Institutes
- 14.3.4 Fertility Centers
- 14.4 East Asia IVF Market by Country (USD Million) [2024-2030]
-
14.5 East Asia IVF Market by Type (USD Million) [2024-2030]
-
14.6 East Asia IVF Market by Application (USD Million) [2024-2030]
Chapter 15 : Southeast Asia IVF Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia IVF Market by Country (USD Million) [2019-2023]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia IVF Market by Type (USD Million) [2019-2023]
- 15.2.1 In Vitro Fertilization
- 15.2.2 Egg Freezing
- 15.2.3 Sperm Donation
- 15.2.4 Cryopreservation
- 15.2.5 Genetic Screening
-
15.3 Southeast Asia IVF Market by Application (USD Million) [2019-2023]
- 15.3.1 Hospitals
- 15.3.2 Clinics
- 15.3.3 Research Institutes
- 15.3.4 Fertility Centers
- 15.4 Southeast Asia IVF Market by Country (USD Million) [2024-2030]
-
15.5 Southeast Asia IVF Market by Type (USD Million) [2024-2030]
-
15.6 Southeast Asia IVF Market by Application (USD Million) [2024-2030]
Chapter 16 : South Asia IVF Market Breakdown by Country, Type & Application
- 16.1 South Asia IVF Market by Country (USD Million) [2019-2023]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia IVF Market by Type (USD Million) [2019-2023]
- 16.2.1 In Vitro Fertilization
- 16.2.2 Egg Freezing
- 16.2.3 Sperm Donation
- 16.2.4 Cryopreservation
- 16.2.5 Genetic Screening
-
16.3 South Asia IVF Market by Application (USD Million) [2019-2023]
- 16.3.1 Hospitals
- 16.3.2 Clinics
- 16.3.3 Research Institutes
- 16.3.4 Fertility Centers
- 16.4 South Asia IVF Market by Country (USD Million) [2024-2030]
-
16.5 South Asia IVF Market by Type (USD Million) [2024-2030]
-
16.6 South Asia IVF Market by Application (USD Million) [2024-2030]
Chapter 17 : Central Asia IVF Market Breakdown by Country, Type & Application
- 17.1 Central Asia IVF Market by Country (USD Million) [2019-2023]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia IVF Market by Type (USD Million) [2019-2023]
- 17.2.1 In Vitro Fertilization
- 17.2.2 Egg Freezing
- 17.2.3 Sperm Donation
- 17.2.4 Cryopreservation
- 17.2.5 Genetic Screening
-
17.3 Central Asia IVF Market by Application (USD Million) [2019-2023]
- 17.3.1 Hospitals
- 17.3.2 Clinics
- 17.3.3 Research Institutes
- 17.3.4 Fertility Centers
- 17.4 Central Asia IVF Market by Country (USD Million) [2024-2030]
-
17.5 Central Asia IVF Market by Type (USD Million) [2024-2030]
-
17.6 Central Asia IVF Market by Application (USD Million) [2024-2030]
Chapter 18 : Oceania IVF Market Breakdown by Country, Type & Application
- 18.1 Oceania IVF Market by Country (USD Million) [2019-2023]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania IVF Market by Type (USD Million) [2019-2023]
- 18.2.1 In Vitro Fertilization
- 18.2.2 Egg Freezing
- 18.2.3 Sperm Donation
- 18.2.4 Cryopreservation
- 18.2.5 Genetic Screening
-
18.3 Oceania IVF Market by Application (USD Million) [2019-2023]
- 18.3.1 Hospitals
- 18.3.2 Clinics
- 18.3.3 Research Institutes
- 18.3.4 Fertility Centers
- 18.4 Oceania IVF Market by Country (USD Million) [2024-2030]
-
18.5 Oceania IVF Market by Type (USD Million) [2024-2030]
-
18.6 Oceania IVF Market by Application (USD Million) [2024-2030]
Chapter 19 : MEA IVF Market Breakdown by Country, Type & Application
- 19.1 MEA IVF Market by Country (USD Million) [2019-2023]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA IVF Market by Type (USD Million) [2019-2023]
- 19.2.1 In Vitro Fertilization
- 19.2.2 Egg Freezing
- 19.2.3 Sperm Donation
- 19.2.4 Cryopreservation
- 19.2.5 Genetic Screening
-
19.3 MEA IVF Market by Application (USD Million) [2019-2023]
- 19.3.1 Hospitals
- 19.3.2 Clinics
- 19.3.3 Research Institutes
- 19.3.4 Fertility Centers
- 19.4 MEA IVF Market by Country (USD Million) [2024-2030]
-
19.5 MEA IVF Market by Type (USD Million) [2024-2030]
-
19.6 MEA IVF Market by Application (USD Million) [2024-2030]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The IVF market may reach an estimated size of 25 Billion by 2030.
According to the report,the IVF Industry size is projected to reach 25 Billion, exhibiting a CAGR of 10% by 2030.
Some of the prominent trends that are influencing and driving the growth of Global IVF Market are Advancements In Genetic Screening, Rise Of Personalized IVF Treatments, Use Of AI In Fertility Clinics
- Growth In Fertility Preservation
- Expansion Of IVF Services
- Increase In Male Infertility Treatments
Some of the major roadblocks that industry players have identified are High Treatment Costs, Ethical Concerns, Low Success Rates.
Some of the opportunities that Analyst at HTF MI have identified in IVF Market are:
- Growth In Fertility Preservation
- Expansion Of IVF Services
- Increase In Male Infertility Treatments
Merck KGaA, Cook Medical, Vitrolife, Irvine Scientific, Ferring Pharmaceuticals, EMD Serono, The Cooper Companies, IBSA, OvaScience, Reproductive Medicine Associates, Bayer, Igenomix, RMA Network, Genea, Meda etc are the main players listed in the Global IVF Market Study.
The Global IVF Market Study is Broken down by applications such as Hospitals, Clinics, Research Institutes, Fertility Centers.
The Global IVF Market Study is segmented by In Vitro Fertilization, Egg Freezing, Sperm Donation, Cryopreservation, Genetic Screening.
The Global IVF Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
Historical Year: 2019 - Base year: 2023. Forecast period**: 2025 to 2030 [** unless otherwise stated]
The IVF market focuses on assisted reproductive technologies, primarily in vitro fertilization (IVF), which helps couples with fertility issues conceive. The market includes egg freezing, sperm donation, and genetic testing.
